Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

The Global Targeted Sequencing Market is poised for growth due to rising demand for precise diagnostics in genetic disorders ...

OGT launches the SureSeq Myeloid MRD Plus Panel, enabling ultra-sensitive MRD detection in AML with variant calls down to ...

According to Brad Schweigert, PXG Chief Operating Officer, "Frequency tuning, structural reinforcement, and advanced MOI engineering allowed us to create metalwoods that are objectively faster and ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

Burning Rock Biotech (BNR) , a precision oncology company from China, has shown exceptional technical momentum and price ...

A new study shows that thanks to cheaper DNA testing, we've reclassified more mammal species and have more biodiversity.

Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI).

Disease development is often shaped by genetics, with how much or how little a gene is expressed influencing disease risk.